Company / Operating Cash Flow
Centessa Pharmaceuticals plc Operating Cash Flow History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$193.8M
FY2025
5-year range
-$200.5M / -$135.1M
FY2021-FY2025
Trend
-36.4%
vs FY2024
Sector context
#169 of 216
Health Care
What the data says
Centessa Pharmaceuticals plc's operating cash flow of -$194M is lower than 78% of companies in the Health Care sector (FY2025). Declined from -$160M to -$194M over the past 2 years.
Based on SEC 10-K filings.
-$194M in FY2025.
Declined from -$160M to -$194M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 22% in Health CareTop 78% of 216This company -$193.8M Sector average $658.7M
▼
-129.4% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow decreased 36.4% year-over-year.
- Ranks #169 out of 216 companies in the Health Care sector.
- Peak operating cash flow was recorded in FY2019.
- Lowest operating cash flow in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.80 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$193.8M | -36.4% |
| FY2024 | -$142.1M | +11.4% |
| FY2023 | -$160.3M | +20.0% |
| FY2022 | -$200.5M | -48.4% |
| FY2021 | -$135.1M | -1171.0% |
| FY2020 | -$10.6M | -82.5% |
| FY2019 | -$5.8M | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026